Adel Ghiaty

740 total citations
21 papers, 659 citations indexed

About

Adel Ghiaty is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Adel Ghiaty has authored 21 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Organic Chemistry, 13 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Adel Ghiaty's work include Synthesis and biological activity (12 papers), Synthesis and Biological Evaluation (10 papers) and Cancer therapeutics and mechanisms (6 papers). Adel Ghiaty is often cited by papers focused on Synthesis and biological activity (12 papers), Synthesis and Biological Evaluation (10 papers) and Cancer therapeutics and mechanisms (6 papers). Adel Ghiaty collaborates with scholars based in Egypt, Saudi Arabia and United States. Adel Ghiaty's co-authors include Ashraf H. Bayoumi, Hamada S. Abulkhair, Ahmed El-morsy, Hany E. A. Ahmed, Abdelrahman S. Mayhoub, Mona S. El‐Zoghbi, Mohamed N. Seleem, Mohamed Hagras, Youssef A. Hegazy and Ebtehal M. Husseiny and has published in prestigious journals such as Journal of Medicinal Chemistry, RSC Advances and European Journal of Medicinal Chemistry.

In The Last Decade

Adel Ghiaty

21 papers receiving 655 citations

Peers

Countries citing papers authored by Adel Ghiaty

Since Specialization

Citations

This map shows the geographic impact of Adel Ghiaty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adel Ghiaty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adel Ghiaty more than expected).

Fields of papers citing papers by Adel Ghiaty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adel Ghiaty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adel Ghiaty. The network helps show where Adel Ghiaty may publish in the future.

Co-authorship network of co-authors of Adel Ghiaty

This figure shows the co-authorship network connecting the top 25 collaborators of Adel Ghiaty. A scholar is included among the top collaborators of Adel Ghiaty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adel Ghiaty. Adel Ghiaty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tailored quinoline hybrids as promising COX-2/15-LOX dual inhibitors endowed with diverse safety profile: Design, synthesis, SAR, and histopathological study 2024 ·Bioorganic Chemistry ·Mohamed‐Elamir F. Hegazy, Ehab S. Taher, Adel Ghiaty, Ashraf H. Bayoumi	6
2	From triazolophthalazines to triazoloquinazolines: A bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity 2021 ·Bioorganic & Medicinal Chemistry ·(unknown), Adel Ghiaty, Ashraf H. Bayoumi, Ahmed A. Al‐Karmalawy, Ebtehal M. Husseiny, Mona S. El‐Zoghbi, Hamada S. Abulkhair	66
3	In vivo‐ and in silico‐driven identification of novel synthetic quinoxalines as anticonvulsants and AMPA inhibitors 2021 ·Archiv der Pharmazie ·Hamada S. Abulkhair, (unknown), Adel Ghiaty, Ahmed El-morsy, Ashraf H. Bayoumi, Hany E. A. Ahmed, Khaled El‐Adl, Mohamed F. Zayed, Memy H. Hassan, (unknown), Mona S. El‐Zoghbi	37
4	1,2,4-Triazolo[4,3-c]quinazolines: a bioisosterism-guided approach towards the development of novel PCAF inhibitors with potential anticancer activity 2021 ·New Journal of Chemistry ·(unknown), Adel Ghiaty, Ashraf H. Bayoumi, Hany E. A. Ahmed, Mona S. El‐Zoghbi, Khaled El‐Adl, Hamada S. Abulkhair	41
5	Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1,2,4]triazolo[4,3-a]quinoxaline analogues targeting DHFR and E. coli DNA gyrase B 2020 ·Bioorganic Chemistry ·Abdelsattar M. Omar, Mohamed Alswah, Hany E. A. Ahmed, Ashraf H. Bayoumi, Kamal M. El‐Gamal, Ahmed El-morsy, Adel Ghiaty, Tarek H. Afifi, Farag F. Sherbiny, (unknown), Basem Mansour	29
6	Design, synthesis, and molecular docking studies of new [1,2,4]triazolo[4,3-a]quinoxaline derivatives as potential A2B receptor antagonists 2020 ·Molecular Diversity ·(unknown), Ashraf H. Bayoumi, Farag F. Sherbiny, Ahmed El-morsy, Adel Ghiaty, Mohamed Alswah, Hamada S. Abulkhair	37
7	Novel triazolophthalazine-hydrazone hybrids as potential PCAF inhibitors: Design, synthesis, in vitro anticancer evaluation, apoptosis, and molecular docking studies 2020 ·Bioorganic Chemistry ·Hamada S. Abulkhair, (unknown), Adel Ghiaty, Hany E. A. Ahmed, Ashraf H. Bayoumi	45
8	Design, synthesis, and antitumor activity of novel compounds based on 1,2,4-triazolophthalazine scaffold: Apoptosis-inductive and PCAF-inhibitory effects 2020 ·Bioorganic Chemistry ·(unknown), Ashraf H. Bayoumi, Adel Ghiaty, Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Hamada S. Abulkhair	41
9	tert-Butylphenylthiazoles with an oxadiazole linker: a novel orally bioavailable class of antibiotics exhibiting antibiofilm activity 2019 ·RSC Advances ·Ahmed Kotb, Nader S. Abutaleb, Mohamed Hagras, Ashraf H. Bayoumi, Mahmoud M. Abd Rabo Moustafa, Adel Ghiaty, Mohamed N. Seleem, Abdelrahman S. Mayhoub	16
10	Exploration of quinoxaline derivatives as antimicrobial and anticancer agents 2019 ·Journal of Heterocyclic Chemistry ·Ashraf H. Bayoumi, Adel Ghiaty, (unknown), Ebtehal M. Husseiny, (unknown)	21
11	4-Substituted benzenesulfonamides featuring cyclic imides moieties exhibit potent and isoform-selective carbonic anhydrase II/IX inhibition 2018 ·Bioorganic Chemistry ·Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Adel Ghiaty, Paola Gratteri, Claudiu T. Supuran, Alessio Nocentini	22
12	Phenylthiazoles with tert-Butyl side chain: Metabolically stable with anti-biofilm activity 2018 ·European Journal of Medicinal Chemistry ·Ahmed Kotb, Nader S. Abutaleb, (unknown), (unknown), Mohamed Hagras, Haroon Mohammad, Ashraf H. Bayoumi, Adel Ghiaty, (unknown), (unknown), Abdelrahman S. Mayhoub	43
13	Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA) 2018 ·European Journal of Medicinal Chemistry ·Mohamed M. Elsebaei, Haroon Mohammad, (unknown), Nader S. Abutaleb, Youssef A. Hegazy, Adel Ghiaty, Lu Chen, (unknown), Satish R. Malwal, Eric Oldfield, Mohamed N. Seleem, Abdelrahman S. Mayhoub	51
14	Biphenylthiazole antibiotics with an oxadiazole linker: An approach to improve physicochemical properties and oral bioavailability 2017 ·European Journal of Medicinal Chemistry ·Mohamed Hagras, Youssef A. Hegazy, (unknown), Haroon Mohammad, Adel Ghiaty, Tamer M. Abdelghany, Mohamed N. Seleem, Abdelrahman S. Mayhoub	26
15	Investigating the Antibacterial Activity of Biphenylthiazoles against Methicillin- and Vancomycin-Resistant Staphylococcus aureus (MRSA and VRSA) 2017 ·Journal of Medicinal Chemistry ·Mohamed Hagras, Haroon Mohammad, (unknown), Youssef A. Hegazy, Adel Ghiaty, Mohamed N. Seleem, Abdelrahman S. Mayhoub	46
16	Synthesis and Antiproliferative Effects of 5,6-Disubstituted Pyridazin-3(2H)-ones Designed as Conformationally Constrained Combretastatin A-4 Analogues 2013 ·Anti-Cancer Agents in Medicinal Chemistry ·Mohamed Elagawany, Martine Schmitt, Adel Ghiaty, (unknown), (unknown), Frédéric Bihel, (unknown), Cláudia Pessoa, Tam Nguyen, Ernest Hamel, Jean Bourguignon	6
17	Design, synthesis, and molecular modelling of pyridazinone and phthalazinone derivatives as protein kinases inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Mohamed Elagawany, Mohamed A. Ibrahim, Hany E. A. Ahmed, (unknown), Adel Ghiaty, Zakaria K. Abdel‐Samii, Said El‐Feky, Jürgen Bajorath	27
18	Synthesis and Biological Evaluation of Some [1,2,4]Triazolo[4,3-a]quinoxaline Derivatives as Novel Anticonvulsant Agents 2013 ·PubMed ·(unknown), Adel Ghiaty, Ahmed El-morsy, Kamal M. El‐Gamal	33
19	Synthesis and Evaluation of Some New (1,2,4) Triazolo(4,3‐a)Quinoxalin‐4(5H)‐one Derivatives as AMPA Receptor Antagonists 2013 ·Journal of Heterocyclic Chemistry ·Hamada S. Abulkhair, (unknown), Ashraf H. Bayoumi, Adel Ghiaty, Ahmed El-morsy, Memy H. Hassan	46
20	Synthesis and evaluation of some new 1,2,4-triazolo(4,3-a)quinoxalin-4-5H-one derivatives as AMPA receptor antagonists 2012 ·Bulletin of Faculty of Pharmacy Cairo University ·Ashraf H. Bayoumi, Adel Ghiaty, Ahmed El-morsy, Hamada S. Abulkhair, Memy H. Hassan, (unknown)	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact